Scientists with the UBC faculty of medicine have received new research funding to prepare and respond to the threat of avian influenza, commonly called ‘bird flu’. Funded by Genome British Columbia… Read More
The approval provides another treatment option for breast cancer patients with a PIK3CA mutation, one of the most commonly mutated genes in hormone receptor-positive disease, associated with poor prognosis.[1,2] MISSISSAUGA,… Read More
Genome British Columbia (Genome BC) is investing in research to address the threat of H5N1, an avian influenza virus that poses a risk to poultry. Recently, British Columbia identified the… Read More
VANCOUVER, BC – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer,… Read More
Bruce Cousins is retiring, and former CFO Alex Rothwell will assume the role VICTORIA, BC – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage biotechnology… Read More
